These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 35111121)

  • 1. Paraneoplastic and Other Autoimmune Encephalitides: Antineuronal Antibodies, T Lymphocytes, and Questions of Pathogenesis.
    Greenlee JE; Carlson NG; Abbatemarco JR; Herdlevær I; Clardy SL; Vedeler CA
    Front Neurol; 2021; 12():744653. PubMed ID: 35111121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunopathology of autoantibody-associated encephalitides: clues for pathogenesis.
    Bien CG; Vincent A; Barnett MH; Becker AJ; Blümcke I; Graus F; Jellinger KA; Reuss DE; Ribalta T; Schlegel J; Sutton I; Lassmann H; Bauer J
    Brain; 2012 May; 135(Pt 5):1622-38. PubMed ID: 22539258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Updates in the Diagnosis and Treatment of Paraneoplastic Neurologic Syndromes.
    Grativvol RS; Cavalcante WCP; Castro LHM; Nitrini R; Simabukuro MM
    Curr Oncol Rep; 2018 Nov; 20(11):92. PubMed ID: 30415318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glutamate receptor antibodies in neurological diseases: anti-AMPA-GluR3 antibodies, anti-NMDA-NR1 antibodies, anti-NMDA-NR2A/B antibodies, anti-mGluR1 antibodies or anti-mGluR5 antibodies are present in subpopulations of patients with either: epilepsy, encephalitis, cerebellar ataxia, systemic lupus erythematosus (SLE) and neuropsychiatric SLE, Sjogren's syndrome, schizophrenia, mania or stroke. These autoimmune anti-glutamate receptor antibodies can bind neurons in few brain regions, activate glutamate receptors, decrease glutamate receptor's expression, impair glutamate-induced signaling and function, activate blood brain barrier endothelial cells, kill neurons, damage the brain, induce behavioral/psychiatric/cognitive abnormalities and ataxia in animal models, and can be removed or silenced in some patients by immunotherapy.
    Levite M
    J Neural Transm (Vienna); 2014 Aug; 121(8):1029-75. PubMed ID: 25081016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoimmune Epilepsy.
    Gaspard N
    Continuum (Minneap Minn); 2016 Feb; 22(1 Epilepsy):227-45. PubMed ID: 26844739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Limbic encephalitis: the new cell membrane antigens and a proposal of clinical-immunological classification with therapeutic implications].
    Dalmau J; Bataller L
    Neurologia; 2007 Oct; 22(8):526-37. PubMed ID: 18000762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paraneoplastic epilepsy.
    Serafini A; Lukas RV; VanHaerents S; Warnke P; Tao JX; Rose S; Wu S
    Epilepsy Behav; 2016 Aug; 61():51-58. PubMed ID: 27304613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glutamate Receptor Antibodies in Autoimmune Central Nervous System Disease: Basic Mechanisms, Clinical Features, and Antibody Detection.
    Scotton WJ; Karim A; Jacob S
    Methods Mol Biol; 2019; 1941():225-255. PubMed ID: 30707437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Neurological syndromes, encephalitis].
    Yamamoto T; Tsuji S
    Gan To Kagaku Ryoho; 2010 Jun; 37(6):995-1005. PubMed ID: 20567100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoimmune Encephalitis: Current Knowledge on Subtypes, Disease Mechanisms and Treatment.
    Nissen MS; Ryding M; Meyer M; Blaabjerg M
    CNS Neurol Disord Drug Targets; 2020; 19(8):584-598. PubMed ID: 32640967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoimmune epilepsy in children: case series and proposed guidelines for identification.
    Suleiman J; Brilot F; Lang B; Vincent A; Dale RC
    Epilepsia; 2013 Jun; 54(6):1036-45. PubMed ID: 23551014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A rare case of anti-LGI1 limbic encephalitis with concomitant positive NMDAR antibodies.
    Ji T; Huang Z; Lian Y; Wang C; Zhang Q; Li J
    BMC Neurol; 2020 Sep; 20(1):336. PubMed ID: 32894089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pathogenesis of paraneoplastic neurological syndromes].
    Tanaka K
    Brain Nerve; 2010 Apr; 62(4):309-18. PubMed ID: 20420170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoimmune central nervous system paraneoplastic disorders: mechanisms, diagnosis, and therapeutic options.
    Dropcho EJ
    Ann Neurol; 1995 May; 37 Suppl 1():S102-13. PubMed ID: 8968221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paraneoplastic autoimmune movement disorders.
    Lim TT
    Parkinsonism Relat Disord; 2017 Nov; 44():106-109. PubMed ID: 29097081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuronal uptake of anti-Hu antibody, but not anti-Ri antibody, leads to cell death in brain slice cultures.
    Greenlee JE; Clawson SA; Hill KE; Wood B; Clardy SL; Tsunoda I; Jaskowski TD; Carlson NG
    J Neuroinflammation; 2014 Sep; 11():160. PubMed ID: 25228406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A large screen for paraneoplastic neurological autoantibodies; diagnosis and predictive values.
    Seluk L; Taliansky A; Yonath H; Gilburd B; Amital H; Shoenfeld Y; Kivity S
    Clin Immunol; 2019 Feb; 199():29-36. PubMed ID: 30543927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paraneoplastic movement disorders.
    Popławska-Domaszewicz K; Florczak-Wyspiańska J; Kozubski W; Michalak S
    Rev Neurosci; 2018 Sep; 29(7):745-755. PubMed ID: 29561731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoimmune channelopathies in paraneoplastic neurological syndromes.
    Joubert B; Honnorat J
    Biochim Biophys Acta; 2015 Oct; 1848(10 Pt B):2665-76. PubMed ID: 25883091
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.